Thyrocare Technologies Reports Robust Q2FY27 Results with 25.1% YoY Revenue Growth
Thyrocare Technologies Ltd 路 Press Release 路 29 Oct 2026, 9:40 pm
Thyrocare Technologies Reports Robust Q2FY27 Results with 25.1% YoY Revenue Growth Thyrocare Technologies reported consolidated revenue of INR 270.8 Cr for Q2FY27, up 25.1% YoY, driven by a 26.7% YoY increase in Pathology. EBITDA grew 24.9% YoY to INR 89.3 Cr, while PAT before exceptional items rose 25.7% YoY to INR 60.2 Cr. Reported PAT stood at INR 15.2 Cr due to a one-time non-cash impairment of INR 45 Cr related to the proposed divestment of the NHL business. Test volumes rose 27.4% YoY to 61.6 million, supported by 12,911 active franchisees.
Original exchange filing (PDF)
More announcements from Thyrocare Technologies Ltd
- Please find the enclosed announcement. 路 06 Nov 2026
- Please find the enclosed intimation. 路 06 Nov 2026
- Please find attached the Earnings Call Transcript held on October 29, 2026 路 02 Nov 2026
- Please find attached Intimation regarding the Execution of Share Purchase Agreement 路 30 Oct 2026
- Audio Recording of Earnings Conference Call for the Quarter and Half Year Ended September 30, 2026 路 30 Oct 2026
- Please find attached the Investor Presentation on the unaudited financial results (standalone and consolidated) for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Please find enclosed the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Please find enclosed outcome of the Board Meeting held on October 29, 2026, inter alia, approving the unaudited financial results for the quarter and half year ended September 30, 2026 .... 路 29 Oct 2026
